Related Experiment Videos
Summary
Nerisona Cream, containing diflucortolone valerate, proved highly effective for inflammatory skin conditions. In a study of 47 patients, it showed excellent results with no observed side effects.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Inflammatory and pruriginous dermatoses represent a significant clinical challenge.
- The need for effective and well-tolerated topical treatments remains high.
Purpose of the Study:
- To evaluate the efficacy and tolerability of Nerisona Cream (diflucortolone valerate 0.1%) in patients with dermatological conditions.
- To assess the cosmetic properties of the investigational preparation.
Main Methods:
- A clinical study involving 47 patients with various inflammatory or pruriginous dermatoses.
- Application of Nerisona Cream (diflucortolone valerate 0.1%).
- Assessment of treatment outcomes and patient-reported cosmetic properties.
Main Results:
- Very good or good results were achieved in 89.3% of the patients treated.
- Nearly all patients reported positive cosmetic properties of the cream.
- No adverse side effects were observed during the study.
Conclusions:
- Nerisona Cream (diflucortolone valerate 0.1%) demonstrates high efficacy and excellent tolerability for treating inflammatory and pruriginous dermatoses.
- The preparation possesses favorable cosmetic properties, contributing to high patient satisfaction.